Use your antibodies-online credentials, if available.
抗Human PLA2G10 抗体:
Human Polyclonal PLA2G10 Primary Antibody for WB - ABIN521874
Ward, Eriksson, Izquierdo-Garcia, Brandes, Ronen: HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells. in PLoS ONE 2013
secretory PLA2s (显示 PLA2G2A 抗体) have important functions as genetic modifiers of inflammation and colon cancer.
PLA2G10 releases omega-3 polyunsaturated fatty acids, suppresses colitis, and promotes sperm fertility.
Progesterone-induced Acrosome Exocytosis Requires Sequential Involvement of Calcium-independent Phospholipase A2beta (iPLA2beta (显示 PLA2G6 抗体)) and Group X Secreted Phospholipase A2 (显示 YWHAZ 抗体) (sPLA2 (显示 PLA2G2A 抗体)).
GX sPLA2 negatively regulated pancreatic insulin (显示 INS 抗体) secretion by augmenting COX-2 (显示 COX2 抗体)-dependent PGE2 production.
Mouse PLA2GX has a unique property of improving fertilization outcome among other secreted phospholipase A2 (显示 YWHAZ 抗体) isoforms.
Data indicate that experimental allergic bronchitis (EAB) in was associated with increased expression of sPLA2 (显示 PLA2G2A 抗体), specifically sPLA2gX, in the lungs.
Authors propose that activation of GX-sPLA2 during H1N1pdm infection is an early step of pulmonary inflammation and its inhibition increases adaptive immunity and improves survival.
Pla2G10 limits the development of atherosclerosis in LDL receptor-nul (显示 HAND1 抗体)l mice.
the use of a highly potent indole-based inhibitor of hGX-sPLA(2 (显示 PLA2G2A 抗体)), RO061606 (which is ineffective against mGX-sPLA(2 (显示 PLA2G2A 抗体))), to assess the potential utility of GX-sPLA(2) blockade as a therapeutic intervention in asthma.
sPLA(2 (显示 PLA2G2A 抗体))-X in neutrophils plays a pathogenic role in abdominal aortic aneurysms in a mouse model.
This report provides the first demonstration that Phosphatidylcholine-Isoprostanes are readily hydrolyzed by group IIA, V and X Secretory Phospholipases A2.
Data show that phospholipase A2 group IIA, V and X have different target/function related activity.
Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils
PLA2G10 variants are not significantly associated with plasma sPLA2 (显示 PLA2G2A 抗体) activity or with CHD (显示 CHDH 抗体) risk.
Studies indicate that the expression of secreted phospholipases A2 (sPLA2s), most notably the group IIA, III and X enzymes, is dysregulated in various malignant tissues.
hGX sPLA2 (显示 PLA2G2A 抗体) is a novel modulator of lipid metabolism that promotes breast cancer cell growth and survival by stimulating lipid droplet formation and fatty acid oxidation.
Data indicate that the expression of genes encoding hGIIA, hGIII and hGX sPLA2s (显示 PLA2G2D 抗体) (PLA2G2A (显示 PLA2G2A 抗体), PLA2G3 (显示 PLA2G3 抗体) and PLA2G10, respectively) in breast tumour biopsies differs from that in normal tissues.
The enzyme activity of sPLA2 (显示 PLA2G2A 抗体) is not altered in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis during the course of the disease.
Secreted phospholipase A2 group X plays a key role in regulating eicosanoid formation and the development of inflammation and airway hyperresponsiveness in murine models.
mouse homolog has phospholipase A2 activity
, group 10 secretory phospholipase A2
, group X secretory phospholipase A2
, phosphatidylcholine 2-acylhydrolase 10
, group X phospholipase A2
, phosphatidylcholine 2-acylhydrolase GX
, phospholipase A2, group 10
, phospholipase A2 group X
, phospholipase A2, group X